Home » Market News » DirectorsTalk Highlights » Study reveals how gut bacteria could affect medical treatments
4d Pharma Plc

Study reveals how gut bacteria could affect medical treatments

Have you ever wonder why a drug that works for someone else doesn’t seem to work for you? It is still a quite mystery for scientists also why certain drugs work well in some people and are completely ineffective in others.

Recent research by the Yale University researchers suggests that a person’s unique gut bacteria population could affect how different oral drugs are metabolized. The new study also has measured how a number of different bacteria interact with over 200 common medications.

 

4D Pharma plc (LON:DDDD) is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.